Literature DB >> 1649214

Reversible male infertility in late onset congenital adrenal hyperplasia.

A Augarten1, R Weissenberg, C Pariente, J Sack.   

Abstract

We have studied a male patient who presented with secondary infertility. His eldest daughter suffers from late onset congenital adrenal hyperplasia. Based on his hormonal profile, adrenal and gonadal stimulation tests, semen analyses and testicular biopsy he was diagnosed as suffering from the same disease as his daughter. Steroid treatment yielded improvement in all the parameters mentioned above. Four months later his wife became pregnant and he fathered a child. Suppression of gonadotropin secretion due to overproduction of adrenal androgens would appear to be the reason for the failure of testicular maturation and spermatogenesis in this patient. We conclude: 1) glucocorticoid treatment is indicated in infertile males suffering from nonclassical 21-hydroxylase deficiency; 2) Late onset congenital adrenal hyperplasia should be suspected in any male infertility of unknown origin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649214     DOI: 10.1007/BF03346799

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  7 in total

1.  Infertility in a man with 21-hydroxylase deficient congenital adrenal hyperplasia.

Authors:  H A Mirsky; J H Hines
Journal:  J Urol       Date:  1989-07       Impact factor: 7.450

Review 2.  Molecular and clinical advances in congenital adrenal hyperplasia.

Authors:  W L Miller; L S Levine
Journal:  J Pediatr       Date:  1987-07       Impact factor: 4.406

Review 3.  Nonclassic adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  S Drucker; M I New
Journal:  Pediatr Clin North Am       Date:  1987-08       Impact factor: 3.278

4.  Reversible male infertility due to congenital adrenal hyperplasia.

Authors:  J Wischusen; H W Baker; B Hudson
Journal:  Clin Endocrinol (Oxf)       Date:  1981-06       Impact factor: 3.478

5.  Male infertility due to congenital adrenal hyperplasia: testicular biopsy findings, hormonal evaluation, and therapeutic results in three patients.

Authors:  A C Bonaccorsi; I Adler; J G Figueiredo
Journal:  Fertil Steril       Date:  1987-04       Impact factor: 7.329

6.  Adult height and fertility in men with congenital virilizing adrenal hyperplasia.

Authors:  M D Urban; P A Lee; C J Migeon
Journal:  N Engl J Med       Date:  1978-12-21       Impact factor: 91.245

7.  Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency.

Authors:  L S Levine; B Dupont; F Lorenzen; S Pang; M Pollack; S E Oberfield; B Kohn; A Lerner; E Cacciari; F Mantero; A Cassio; C Scaroni; G Chiumello; G F Rondanini; L Gargantini; G Giovannelli; R Virdis; E Bartolotta; C Migliori; C Pintor; L Tato; F Barboni; M I New
Journal:  J Clin Endocrinol Metab       Date:  1981-12       Impact factor: 5.958

  7 in total
  9 in total

Review 1.  Non-classic adrenal hyperplasia in hyperandrogenism: a reappraisal.

Authors:  C Morán; E S Knochenhauer; R Azziz
Journal:  J Endocrinol Invest       Date:  1998-11       Impact factor: 4.256

Review 2.  Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): an update.

Authors:  Christine M Trapp; Sharon E Oberfield
Journal:  Steroids       Date:  2011-12-13       Impact factor: 2.668

3.  Genotyping of congenital adrenal hyperplasia due to 21-hydroxylase deficiency presenting as male infertility: case report and literature review.

Authors:  Y Sugino; T Usui; K Okubo; K Nagahama; T Takahashi; H Okuno; H Hatayama; O Ogawa; A Shimatsu; H Nishiyama
Journal:  J Assist Reprod Genet       Date:  2006-10-11       Impact factor: 3.412

4.  Pituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency.

Authors:  J Jääskeläinen; O Kiekara; M Hippeläinen; R Voutilainen
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

5.  An 88-year-old woman diagnosed with adrenal tumor and congenital adrenal hyperplasia: connection or coincidence?

Authors:  H Falhammar; M Thorén
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

Review 6.  Nonclassic adrenal hyperplasia.

Authors:  Phyllis W Speiser
Journal:  Rev Endocr Metab Disord       Date:  2009-03       Impact factor: 6.514

7.  Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency.

Authors:  L Foppiani; M Baffico; G Lando; C Cappi; P De Cassan; M C Patrosso; A Vitali; S Penco; M Giusti; F Minuto
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

Review 8.  Medical management of non-obstructive azoospermia.

Authors:  Rajeev Kumar
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

9.  Nonclassical Congenital Adrenal Hyperplasia and Pregnancy.

Authors:  Neslihan Cuhaci; Cevdet Aydın; Ahmet Yesilyurt; Ferda Alpaslan Pınarlı; Reyhan Ersoy; Bekir Cakir
Journal:  Case Rep Endocrinol       Date:  2015-10-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.